Brief: Allergy Therapeutics Extends Cash Runway Into Q1 Of FY25

Allergy Therapeutics

27/03/2024 07:35

March 27 (Reuters) - Allergy Therapeutics PLC  AGY.L :
    * ALLERGY THERAPEUTICS- LENDERS AGREED THAT A FURTHER £15M
FROM
EXISTING £40M AMENDED LOAN FACILITY MAY BE DRAWN DOWN FROM Q2
CALENDAR YEAR 2024.
    * ALLERGY THERAPEUTICS PLC - EXTENDED ITS CASH RUNWAY INTO
Q1
FY2025.

Source text for Eikon:  ID:nRSa4179Ia 
Further company coverage:  AGY.L 

 ((Reuters.Briefs@thomsonreuters.com;))